Eli Lilly and Company(LLY)
Focus: Eli Lilly is a large-cap public pharmaceutical company with 43,000 employees headquartered in Indianapolis, specializing in biologics discovery across diabetes, oncology, neuroscience, and immunology. The company generated $34.1B in FY 2025 revenue with strong market presence in GLP-1 agonists and kinase inhibitors.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
43,000
Open Jobs
0
About Eli Lilly and Company
AI assessmentNot HiringNo open roles listed right now. Follow Eli Lilly and Company to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
5/9 — Partial
Company HealthSolid
Pipeline
Early-stage
50 total
LOE Risk
1 imminent
AXIRON
Hiring
Stable
Revenue
$34.1B
FY2025
Key Products
Peak
Flagship product generating 59% of company revenue; peak-stage with no disclosed LOE, but faces biosimilar competition and market share pressure from MOUNJARO.
Help build intelligence for Eli Lilly and Company
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.